Sponsor or institution

Clinical trials and research at AGO Research GmbH

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Pembrolizumab plus lenvatinib for recurrent or advanced vulvar cancer

  This study will try pembrolizumab plus lenvatinib for people with recurrent, persistent, metastatic, or locally advanced vulvar cancer that cannot be cured with surgery or radiotherapy.

  Recruiting at 14 sites Phase 2 AGO Research GmbH · Augsburg and 14 other locations · NCT05903833

• Combination treatment of Olaparib and Durvalumab for advanced ovarian cancer

  This study is testing if a combination of two drugs, Olaparib and Durvalumab, can help people with advanced ovarian cancer feel better after their initial chemotherapy.

  Recruiting at 6 sites Phase 2 AGO Research GmbH · Mannheim, Baden-Wurttemberg and 5 other locations · NCT04644289

Quick answers

How many clinical trials run by AGO Research GmbH are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Germany. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →